Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 管理學院
  3. 商學組
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27825
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor江炯聰
dc.contributor.authorChun-Ming Huangen
dc.contributor.author黃俊銘zh_TW
dc.date.accessioned2021-06-12T18:22:38Z-
dc.date.available2007-08-28
dc.date.copyright2007-08-28
dc.date.issued2007
dc.date.submitted2007-08-20
dc.identifier.citationYearbook of Biotechnology Industry 2006/ Development Center for Biotechnology
GPN: 1009500959
ISBN: 957-8514-69-7

A Survey of the Use of Biotechnology in U.S. Industry
Technology Administration, U.S. Department of Commerce, October 2003.
http://www.technology.gov/reports/Biotechnology/CD120a_0310.pdf
Frequently Asked Questions about Biotechnology
U.S. Department of State Fact Sheet, March 21, 2000.
http://usinfo.state.gov/ei/economic_issues/biotechnology/biotech_faq.html
Beyond Therapy: Biotechnology and the Pursuit of Happiness
The President's Council on Bioethics, Washington, D.C., October 2003. An inquiry into the potential implications of using biotechnology beyond therapy,?in order to try to satisfy deep and familiar human desires: for better children, superior performance, ageless bodies, and happy souls.
http://www.bioethics.gov/reports/beyondtherapy/index.html
United States Regulatory Oversight in Biotechnology Responsible Agencies - Overview
U.S. Department of Agriculture. The Agencies primarily responsible for regulating biotechnology in the United States are the US Department of Agriculture (USDA), Environmental Protection Agency (EPA), and the Food and Drug Administration (FDA). Products are regulated according to their intended use, with some products being regulated under more than one agency.
http://www.aphis.usda.gov/brs/usregs.html
USDA Announces First Steps To Update Biotechnology Regulations
U.S. Department of Agriculture Press Release Jan 22, 2004. Agriculture Secretary Ann M. Veneman announces USDA intention to update and strengthen its biotechnology regulations for the importation, interstate movement and environmental release of certain genetically engineered (GE) organisms.
http://www.usda.gov/Newsroom/0033.04.htm
About The Human Genome Project
National Human Genome Research Institute, updated February 2004.
http://www.genome.gov/10001772
A Vision for the Future of Genomics Research
National Human Genome Research Institute, reprinted from 'Nature', April 14, 2003.
http://www.genome.gov/Pages/About/vision.pdf
National Center for Biotechnology Information
www.ncbi.nlm.nih.gov/
The Promise of Biotechnology, eJournal USA: Economic Perspectives ...
www.usinfo.state.gov/journals/ites/1005/ijee/ijee1005.htm

OECD biotechnology newsletter updates
www.oecd.org/document/52/0,3343,en_2649_37437_2078004_1_1_1_37437,00.html
BioTrack Product Database - Home page
www.2.oecd.org/biotech/

Biotechnology: USA (Atlanta)
By 2001, the United States Patent and Trademark Office (USPTO) received 34527 biotechnology patent applications. A new report indicates patents on genes and proteins--representing potential drug targets--are quickly becoming the ...
www.giichinese.com.tw/chinese/dm33791-postgenomic.html
Pharmaceutical market
World pharmaceutical market. Year 1996,1997,1998, 1999, 2000, 2001, 2002
2003, 2004 ... USA: US$ 417m Japan: US$ 445m. 1998 2004. Frost & Sullivan. WM cell therapies and tissue repair. cell therapies: US$ 14.572bn ...
www.i-s-b.org/business/pharma.htm

Taiwan Yearbook 2004
Government biotechnology R&D expenditures in 2003 was about US$485 million. Taiwan and its people have various ... The government has constructed a blueprint for the special biotech and medical area in the Hsinchu Science Park. ...
www.ecommerce.taipeitimes.com/yearbook2004/P177.htm

BioEconomy
These are not targets to be left on the shelf: the USA has a clear commitment to their achievement. .... An action plan covering biotechnology strategy guidelines was published by the government-sponsored Biotechnology Strategy Council ...
www.bio-economy.net/centre3.html
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27825-
dc.description.abstract生技產業是許多國家想要發展的領域。然而,什麼是生技產業,可能有不同的看法與定義。本文首先給生技定義並舉出在產業上的應用及其在財政與經濟上的衝擊。
從生技產業萌芽開始,美國就領導世界的生技產業。本文第二部分,從世界產業競爭的角度,探討美國生技產業的地位。並分析美國生技產業的成功因素,並找出四個成功因素。第一個因素是從聯邦政府與產業界來的巨大研發投資。第二是政府在策略,法規,與立法方面的鼓勵措施。第三是從市場面分析,而美國是世界最大的藥品市場,有50%的市占率。最後一個因素是健全的資本市場,包括股市與創投。
最後,則以美國的成功因素來分析台灣生技產業的發展,並嘗試指出其產業發展的策略意涵。
zh_TW
dc.description.abstractBiotechnology is one of the scientific fields that many countries would like to encourage and develop. However, what is the scope of biotechnology industry? There might have different views and definition. In this article, it first gives the definition of biotechnology and its industrial applications and its impacts financial and economic fields.
From the blooming of biotechnology industries, USA has been the leading country in the world. In the second paragraph, the article discusses development of biotechnology in USA from the global point of views, and positions the US biotech industry among the international competition, to evaluate the successful factors of US biotech industry. There are four aspects being analyzed and identified. The first is the huge investment in research and development from the Federal government and from the industry. The second is the governmental strategies, regulations, and laws to encourage the industry. The third is the market capacity, since the US is occupying 50% of the total pharmaceutical market in the world. The last one is the capital market is very friendly to the biotech industry, with very mature stock markets and venture capitals.
The last paragraph analyzes the gaps of Taiwan in the development of biotech industry based on the successful factors found in the US counterpart, and tries to make the recommendations and conclusions in terms of strategic implications.
en
dc.description.provenanceMade available in DSpace on 2021-06-12T18:22:38Z (GMT). No. of bitstreams: 1
ntu-96-R90741019-1.pdf: 862592 bytes, checksum: 48d087c8b3eec949001038e74f57ce25 (MD5)
Previous issue date: 2007
en
dc.description.tableofcontentsTable of Contents
口試委員審定書  
誌謝……………………………………………………………….. 2
中文摘要 ………………………………………………………………… 3
英文摘要 ………………………………………………………………… 4
I: What is Biotechnology: The Definition and Background Information of Biotechnology ……………………………………………………………...8 I.1 The Definition of Biotechnology ……………………………………….8
I.2 The Impact and Challenges of Biotechnology ………………………...16
II The Development of Biotechnology Industry in USA: From the Global Point of Views …………………………………………………………….22
II.1 The Position and Development of Biotechnology Industry in USA among the International Competition ……………………………………..22
II.1 a : The Global Aspects ……………………………………………….22
II.2 The Biotechnology Industry in USA …………………………………31
II.2.a The Strategic and Economic Aspects of Biotechnology in USA ..…31
II.2.b The Current Development of Biotechnology Industry in USA ……35
II.2.c The Successful Factors of Biotechnology Industry in USA…………38
II.3: The Successful Factors from the Analysis……………………………39
II.3.1: The R&D Basis: the federal government and industry……………...39
II.3.2: The Governmental Strategies……………………………………....51
II.3.3: The Market for Pharmaceutical and Biotechnological Products…...54
II.3.4: The Capital Market: Venture capital and financial markets………...61
III: TAIWAN: Could we Succeed? And How? ……………………………65
III.I: Background Information……………………………………………...65
III.2: The Checking Criteria for the Successful Factors……………………67
III.2.1: The Checking Criteria: the R&D Capacity of Biotechnology in Taiwan……………………………………………………………………...67
III.2.2: The Checking Criteria: the Governmental Strategies……………...73
III.2.3: The Checking Criteria: the Market for Pharmaceutical and Biopharmaceutical Products……………………………………………….74
III.2.4: The Checking Criteria: The Capital Market—the Venture Capitals and Financial Markets …………………………………………………….77
IV: The Conclusion ……………………………………………………….82
Reference…………………………………………………………………..84
dc.language.isozh-TW
dc.subject製藥zh_TW
dc.subject專利zh_TW
dc.subject生物技術zh_TW
dc.subjectbiotechnologyen
dc.subjectpharmaceuticalen
dc.subjectpatenten
dc.title美國生技產業分析及其對台灣的策略意涵zh_TW
dc.titleAn Analysis of US Biotechnology Industry and its Strategic Implications for Taiwanen
dc.typeThesis
dc.date.schoolyear95-2
dc.description.degree碩士
dc.contributor.oralexamcommittee張睿詒,承立平
dc.subject.keyword生物技術,專利,製藥,zh_TW
dc.subject.keywordbiotechnology,patent,pharmaceutical,en
dc.relation.page86
dc.rights.note有償授權
dc.date.accepted2007-08-20
dc.contributor.author-college管理學院zh_TW
dc.contributor.author-dept商學組zh_TW
顯示於系所單位:商學組

文件中的檔案:
檔案 大小格式 
ntu-96-1.pdf
  未授權公開取用
842.38 kBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved